Lightnews — Scholar-powered news

Sage Journals: Discover world-class research

October 24, 2025 at 8:45 PM Everybody can reply

Therapeutic Advances in Medical Oncology

@tamedoncol.bsky.social

🧠 New real-world data on HER2-positive MIBC suggests limited benefit from adjuvant chemo or targeted therapy.
With a 5-year DFS of 95.1%, this @tamedoncol.bsky.social study raises important questions about treatment necessity
🔗 buff.ly/HBeagpd
#BreastCancer #HER2 #OncologyResearch

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

October 24, 2025 at 7:15 AM Everybody can reply

1 reposts 1 likes

'Weaponised' CAR T-cell therapy shows promise against solid tumours

Pure Science

@purescience.news

'Weaponised' CAR T-cell therapy shows promise against solid tumours #Science #HealthandMedicine #Oncology #CARtherapy #OncologyResearch #SolidTumors

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid cancers - but a study in mice suggests that could soon change

October 23, 2025 at 8:01 AM Everybody can reply

1 likes

Lingling Tian

@linglingtian.bsky.social

📊 Real-world data from Spain shows that nal-IRI + 5-FU/LV offers survival benefits for patients with advanced #PDAC, with outcomes comparable to clinical trials.
Dive into the full TAMO study: buff.ly/hOvxr4Q
#PancreaticCancer #RealWorldEvidence #TAMO #ESMO25 #OncologyResearch

October 23, 2025 at 7:15 AM Everybody can reply

1 reposts 1 likes

Elizabeth Forde

@elizabethforde.bsky.social

Calling all Radiation Therapists (RTTs)! 🌍
We’re mapping how RTTs contribute to clinical trials worldwide.

Your input matters! Help shape the global picture!

Take the anonymous survey here: tcdhealthsciences.qualtrics.com/jfe/form/SV_...

#RadiationTherapy #RTT #ClinicalTrials #OncologyResearch

October 20, 2025 at 4:28 PM Everybody can reply

1 reposts 1 likes

Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond - Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara, 2025

Therapeutic Advances in Medical Oncology

@tamedoncol.bsky.social

🚀 The future of #GastricCancer therapy may lie beyond traditional oncogenic targets.
Explore how Claudin18.2, Nectin-4, and Caprin-1 are opening new doors for precision oncology in this @tamedoncol.bsky.social review.
🔗 journals.sagepub.com/doi/full/10....
#OncologyResearch #ESMO25 #CancerTherapy

Human epidermal growth factor receptor 2 was the first successful molecular target in treating gastric cancer, marking a significant milestone for targeted ther...

journals.sagepub.com

October 20, 2025 at 7:15 AM Everybody can reply

1 reposts 1 likes

Sage Journals: Discover world-class research

Lingling Tian

@linglingtian.bsky.social

Following the buzz around #ESMO25?
Dive deeper with our review article - a timely read as we explore the future of ADCs.
🔗https://buff.ly/ovkYahi
#ADC #CancerTherapy #OncologyResearcH

Subscription and open access journals from Sage, the world's leading independent academic publisher.

buff.ly

October 19, 2025 at 7:15 AM Everybody can reply

1 reposts 1 likes

#BreastCancerResearch #AdjuvantTherapy #CancerOutcomes #OncologyResearch #RadiationTherapy #CancerTreatment #MSKResearch #ClinicalOncology #CancerSurvivorship #MSKInnovation #JAMANetworkOpen

ONCOassist® | The go-to oncology app

@oncoassist.bsky.social

Test Banner

bit.ly

October 17, 2025 at 2:11 PM Everybody can reply

ONCOassist® | The go-to oncology app

@oncoassist.bsky.social

💊 It’s the first immune checkpoint inhibitor-based regimen in this setting to demonstrate OS benefit vs. placebo + chemotherapy (± bevacizumab).

🔗 Read more: bit.ly/ONCOnews17O-1

#ONCOnews #OncoAlert #OncEd #OvarianCancer #OncologyResearch #CancerTreatment #ESMO2025

October 17, 2025 at 11:00 AM Everybody can reply

Genes & Diseases Journal

@genesndiseases.bsky.social

Did you know there's a YouTube channel just for Genes & Diseases content?
Subscribe here: www.youtube.com/@GenesNDisea...
#GeneticsResearch #OncologyResearch

October 15, 2025 at 4:39 PM Everybody can reply

MSK Library

@msklibrary.bsky.social

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 20d

MSK researchers found that locoregional recurrence (LRR) rates were significantly lower for #breastcancer patients who completed at least one form of adjuvant therapy after #lumpectomy.

Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer

When considering adjuvant therapy preferences for younger patients ages 50 to 69 with early-stage, low genomic risk breast cancer, is it reasonable to omit radiotherapy or endocrine therapy after lump...

www.mskcc.org

October 14, 2025 at 5:09 PM Everybody can reply

1 likes

New Light-Based Therapy Kills 92% of Skin Cancer Cells Without Harming Healthy Tissue

International Society of Liquid Biopsy

@islb.info

We’re pleased to present the #ISLB25 Research Award to Dr. Maria Arcila for her leadership in molecular diagnostics and translational oncology.

Celebrate her impact this November in Orlando. 🔗 2025.islb.info

#ResearchAward #LiquidBiopsy #OncologyResearch

October 14, 2025 at 3:28 PM Everybody can reply

MedChemExpress

@medchemexpress.bsky.social

💡 Dual degradation helps overcome drug resistance in breast cancer and restores immune response in resistant models.
www.nature.com/articles/s41...

#DrugResistance #OncologyResearch #CancerBiology #EGFR #HER2 #PDL1 #VISTA

Client Challenge

www.nature.com

October 14, 2025 at 10:30 AM Everybody can reply

Pure Science

@purescience.news

New Light-Based Therapy Kills 92% of Skin Cancer Cells Without Harming Healthy Tissue #Science #HealthandMedicine #Oncology #SkinCancer #LightTherapy #OncologyResearch

Scientists have created a new light-based cancer therapy that targets tumors precisely without harming healthy cells. Scientists have developed a new cancer therapy that uses LED light and microscopic...

October 12, 2025 at 6:00 PM Everybody can reply

1 likes

Cambridge Bioscience

@cambridgebio.bsky.social

We've also put together the references below - take a look!

2/2
#Oncology #OncologyResearch #CancerResearch

October 9, 2025 at 1:22 PM Everybody can reply

Genes & Diseases Journal

@genesndiseases.bsky.social

Genes & Diseases official YouTube channel is live and growing.
Explore it here: www.youtube.com/@GenesNDisea...
#GeneticsResearch #OncologyResearch

September 30, 2025 at 3:34 PM Everybody can reply

1 likes

Novogene Europe

@novogene-europe.bsky.social

Explore the role of whole transcriptome sequencing in cancer research. Uncover how this technique reveals gene expression and pathways to accelerate discoveries in oncology.

Read more: https://bit.ly/4gH9pHv

#Transcriptomics #GeneExpression #CancerResearch #WholeTranscriptome #OncologyResearch

September 30, 2025 at 7:05 AM Everybody can reply

1 likes

“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers

European Society for Radiotherapy and Oncology (ESTRO)

@estroradiotherapy.bsky.social

#ProtonTherapy’s biological impact goes beyond a fixed RBE: Preclinical studies show the need to better understand LET, fractionation & toxicity to refine treatment.
👉 bit.ly/3Vktrz5
#Radiobiology #OncologyResearch #Radiotherapy

September 29, 2025 at 8:03 AM Everybody can reply

Pure Science

@purescience.news

“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers #Science #HealthandMedicine #Oncology #BloodCancer #OncologyResearch #Genetics

“Junk DNA” may hold the key to treating tough cancers. Existing drugs exploit weaknesses in cells with gene mutations. Researchers at King’s College London have identified a promising strategy for...

September 26, 2025 at 10:00 AM Everybody can reply

1 likes